| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKR1B1
|
aldo-keto reductase family 1, member B1 (aldose reductase)
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APC
|
adenomatous polyposis coli
|
|
APOC2
|
apolipoprotein C-II
|
|
AR
|
androgen receptor
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1G
|
calcium channel, voltage-dependent, T type, alpha 1G subunit
|
|
CALCA
|
calcitonin-related polypeptide alpha
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CALR
|
calreticulin
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CGA
|
glycoprotein hormones, alpha polypeptide
|
|
COX7A2L
|
cytochrome c oxidase subunit VIIa polypeptide 2 like
|
|
CSNK2B
|
casein kinase 2, beta polypeptide
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSL
|
cathepsin L
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDNRB
|
endothelin receptor type B
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR4
|
early growth response 4
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FKBP4
|
FK506 binding protein 4, 59kDa
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GP1BB
|
glycoprotein Ib (platelet), beta polypeptide
|
|
GPR37
|
G protein-coupled receptor 37 (endothelin receptor type B-like)
|
|
GRIN2D
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HLA-F
|
major histocompatibility complex, class I, F
|
|
HOXA5
|
homeobox A5
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
ING4
|
inhibitor of growth family, member 4
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
MAPKAPK5
|
mitogen-activated protein kinase-activated protein kinase 5
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MSMB
|
microseminoprotein, beta-
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYOD1
|
myogenic differentiation 1
|
|
NAIP
|
NLR family, apoptosis inhibitory protein
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
PAX6
|
paired box 6
|
|
PGR
|
progesterone receptor
|
|
PITX2
|
paired-like homeodomain 2
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PRKCD
|
protein kinase C, delta
|
|
PSAT1
|
phosphoserine aminotransferase 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
REN
|
renin
|
|
RENBP
|
renin binding protein
|
|
S100A2
|
S100 calcium binding protein A2
|
|
SDC4
|
syndecan 4
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFN
|
stratifin
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN1
|
stathmin 1
|
|
SYK
|
spleen tyrosine kinase
|
|
TES
|
testin LIM domain protein
|
|
TFF1
|
trefoil factor 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGM4
|
transglutaminase 4
|
|
THBS1
|
thrombospondin 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TK2
|
thymidine kinase 2, mitochondrial
|
|
TMEFF2
|
transmembrane protein with EGF-like and two follistatin-like domains 2
|
|
TP53
|
tumor protein p53
|
|
TP73
|
tumor protein p73
|
|
TRIM16
|
tripartite motif containing 16
|
|
TRIM25
|
tripartite motif containing 25
|
|
TUSC3
|
tumor suppressor candidate 3
|
|
VCAN
|
versican
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
WT1
|
Wilms tumor 1
|